CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
מצבים רפואיים
Type 1 Diabetes Mellitus · T1D · T1DM · T1DM - Type 1 Diabetes Mellitus · Type 1 Diabetes in Adolescence · Type 1 Diabetes in Children · Type 1 Diabetes (Juvenile Onset) · Type 1 Diabetes · Type 1 Diabetes Patients · Type 1 Diabetes Mellitis
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Wake Research - Tucson, Tucson, Arizona, United States
Contact: Principal Investigator (David Alster)Liver Institute PLLC, Tucson, Arizona, United States
Contact: Principal Investigator (Neda Ebrahimi)Rady Children's Hospital San Diego, San Diego, California, United States
Contact: Principal Investigator (Carla Demeterco-Berggren)Diablo Clinical Research, Walnut Creek, California, United States
Contact: Principal Investigator (Mark Christiansen)Barbara Davis Center for Childhood Diabetes, Aurora, Colorado, United States
Contact: Principal Investigator (Taylor Triolo)University of Florida, Gainesville, Florida, United States
Contact: Principal Investigator (Timothy Foster)Evolution Research Center, Hialeah, Florida, United States
Contact: Principal Investigator (Andrea Sosa-Melo)University of Miami, Miami, Florida, United States
Contact: Principal Investigator (David Baidal)DY Professional Research Center, Miami, Florida, United States
Contact: Principal Investigator (Soroush Aghigh)University of South Florida, Tampa, Florida, United States
Contact: Principal Investigator (Henry Rodriguez)Atlanta Diabetes Association, Atlanta, Georgia, United States
Contact: Principal Investigator (Carson Womack)Emory University, Atlanta, Georgia, United States
Contact: Principal Investigator (Michael Hughes)Southern Illinois University School of Medicine, Springfield, Illinois, United States
Contact: Principal Investigator (Gabriel Uwaifo)Riley Hospital for Children- Indiana University, Indianapolis, Indiana, United States
Contact: Principal Investigator (Linda DeMeglio)Barry J. Reiner, MD, LLC, Baltimore, Maryland, United States
Contact: Principal Investigator (Barry Reiner)Joslin Diabetes Center, Boston, Massachusetts, United States
Contact: Principal Investigator (Jason Gaglia)Embassy Research Network, Bloomfield Township, Michigan, United States
Contact: Principal Investigator (George Grunberger)University of Minnesota, Minneapolis, Minnesota, United States
Contact: Principal Investigator (Antoinette Moran)Children's Mercy Hospital, Kansas City, Missouri, United States
Contact: Principal Investigator (Wayne Moore)Washington University School of Medicine, St Louis, Missouri, United States
Contact: Principal Investigator (Janet McGill)UBMD Pediatrics - University of Buffalo, Buffalo, New York, United States
Contact: Principal Investigator (Lucy Mastrandrea)MainStreet Health, Syosset, New York, United States
Contact: Principal Investigator (Alla Khalfin)Duke University, Durham, North Carolina, United States
Contact: Principal Investigator (Jennifer Green)Physicians East, PA, Greenville, North Carolina, United States
Contact: Principal Investigator (Mark Warren)Wake Research - Raleigh, Raleigh, North Carolina, United States
Contact: Principal Investigator (Khushbu Chandarana)Superior Clinical Research, Smithfield, North Carolina, United States
Contact: Principal Investigator (Clifford Curtis)University Diabetes & Endocrine Consultants, Chattanooga, Tennessee, United States
Contact: Principal Investigator (David Huffman)Texas Diabetes & Endocrinology, Austin, Texas, United States
Contact: Principal Investigator (Jean Chen)M3 Wake Research - Dallas, Dallas, Texas, United States
Contact: Principal Investigator (Carlos Arauz-Pacheco)Accurate Clinical Research, Inc, Humble, Texas, United States
Contact: Principal Investigator (Brian Chou)Diabetes & Glandular Disease (DGD) Clinic, P.A., San Antonio, Texas, United States
Contact: Principal Investigator (Mark Kipnes)TopLine Clinical, Inc, Waxahachie, Texas, United States
Contact: Principal Investigator (Stephen Mueller)University of Washington Diabetes Institute, Seattle, Washington, United States
Contact: Principal Investigator (Irl Hirsch)
מובילי המחקר
Paul Peloso, MD
Study Director
COUR Pharma